Street View

Street View — Rashi Peripherals Ltd (RASHIPERIP)

Street View in One Page

Institutional sell-side coverage of RPTECH is sparse — the company only listed in February 2024 and carries a ₹3,497 Cr market cap — but the three known analyst ratings (MOFSL, YES Securities, JM Financial) are uniformly Neutral with targets of ₹405–430, all now 19–24% below the current price of ₹530.6. The directional picture on estimates is rising: FY26 revenue and EBITDA are tracking above FY25, and Q3 FY26 delivered a blowout +42.6% revenue and +453% EBITDA YoY print. However, the stock has massively overrun every published analyst target, meaning the re-rating thesis ("cheap IT distributor → AI infrastructure beneficiary") has already occurred; the question for the street is whether FY27 earnings, anchored by the new Dell partnership, justify a further leg up. The single event that will most likely force the next round of estimate revisions is the Q4 FY26 results board meeting on 14 May 2026, which will confirm or deny the Q3 demand-pull-forward thesis and deliver the first formal FY27 guidance.

Consensus Buy (%)

0

Consensus Target (₹)

418

Implied Upside (%)

-21.2

Estimate Revision

0%

Consensus Snapshot

Formal sell-side consensus estimates are not available for RPTECH on standard Indian platforms (Moneycontrol, ICICI Direct). This is consistent with the company's nine-quarter post-IPO age and small-cap status. The table below uses available directional evidence from research reports and earnings data to reconstruct where estimates stand.

No Results

Rating distribution — the three known institutional ratings (MOFSL, YES Securities, JM Financial) are all Neutral. No institutional Buy ratings have been published.

Loading...

All three known institutional ratings are Neutral, set in the context of a stock trading at ₹530.6 — well above the most bullish target of ₹430. The Neutral calls reflect caution around thin margins and governance concerns rather than a structural bear case. MarketsMojo (algorithmic aggregator) upgraded from Hold → Buy (February 5, 2026) → Strong Buy (April 8, 2026), driven by improving technicals and Q3 FY26 results, a rating maintained as of May 8, 2026.


Estimate Revision Trend

Formal point-in-time estimate history is unavailable. The revision trend is reconstructed from directional evidence.

No Results

The revision trend is directionally Rising but in an unusual configuration: actual reported numbers have beaten the implied post-IPO trajectory (Q3 FY26 EBITDA +453% YoY vs the prior year's weakness), and the only research firm to publish explicit FY25–28 estimates (MNCL Group, December 2025) is constructive on the multi-year earnings trajectory. The paradox is that the stock has accelerated so rapidly — from ~₹266 (52-week low, March 2025) to ₹530.6 (May 2026) — that even rising estimates have been unable to justify the stock at current levels on a standard P/E or target-price basis. The revision cycle is accelerating into the Q4 FY26 print (May 14), and FY27 guidance from management will determine whether sell-side targets see a step-change upward revision or whether current market pricing is validated as forward-looking and already discounting FY27.


Rating Actions (Last 12 Months)

Formal institutional rating changes (upgrades, downgrades) are limited given thin coverage. The table includes all known rating events.

No Results

The direction of travel is clearly more positive: the only rating changes in the past twelve months have been upgrades, driven by improving fundamentals (positive OCF in H1 FY26, CRISIL double upgrade in September 2025, Q3 FY26 blowout). However, all three institutional sell-side firms with known targets (MOFSL, YES Securities, JM Financial) are uniformly Neutral at ₹405–430, last published when the stock was around ₹348. With the stock now at ₹530.6 — 19–24% above every published target — the street has either not updated its targets (highly likely given thin coverage and a rapidly moving stock) or is broadly signalling that the re-rating is overdone. Institutional upgrades to Buy, if they come, would most likely follow a strong Q4 print and constructive FY27 guidance on May 14–15.


Short Interest and Borrow

The structural picture on short interest is inferred from ownership data:

  • FII holding: 0.78% (22 foreign institutional investors, March 2026) — declining from 1.63% at IPO. This is an extremely low FII stake for a listed company, suggesting institutional bears have expressed their view through selling rather than shorting.
  • Promoter holding: 64.01% with zero pledges. Combined with 17.45% DII (structural buyers), effective free float is approximately 18% once Bandhan Small Cap Fund's 7.58% long-only stake is excluded.
  • Declining shareholder count: 64,015 (IPO) → 43,946 (March 2026) — retail distribution is concentrating, not broadening.

The combination of low float, a dominant domestic institutional holder (Bandhan), zero promoter pledging, and negligible FII participation strongly implies short interest is de minimis. There is no evidence of a short-seller campaign against RPTECH, and the stock's 99% one-year return is inconsistent with sustained short pressure. The low FII presence cuts both ways: it removes organised short-selling risk, but it also signals limited global institutional appetite at current valuations — which constrains multiple expansion beyond 14–15x P/E.


What the Street Will Watch Next

No Results

The most time-sensitive trigger is Q4 FY26 results on May 14, three days from today. Analysts were expecting revenue of ₹4,800–5,200 Cr and PAT of ₹46–55 Cr in their April 28 preview. More important than the Q4 number itself is the FY27 revenue guidance and any concrete update on the Dell Technologies ramp — two data points that could materially shift the known analyst targets of ₹405–430 toward ₹500+ if bullish, or confirm the market has run ahead of fundamentals if cautious.


Where This Report Diverges from Consensus

The key divergence from the known institutional consensus (all three Neutral, targets ₹405–430) lies in the Dell Technologies FY27 catalyst: the August 2025 authorization to distribute Dell's full portfolio across India is absent from any published analyst model. If Dell adds 5–10% incremental revenue in FY27 — which management has explicitly flagged as "significant from FY27" — it would compress the implied FY27 P/E from the current ~12.5x to closer than 10x on a ₹530 price, making current neutrals look incorrectly calibrated. The street would have to concede this if Q4 FY26 or early FY27 channel checks show Dell pipeline materialising. Consensus convergence is most likely triggered by a strong Q4 FY26 print on May 14 followed by constructive Dell commentary at the May 15 investor meeting — the two-day window that will either reset or confirm the current divergence.